ZA988030B - Fracture healing using pthrp analogs - Google Patents

Fracture healing using pthrp analogs

Info

Publication number
ZA988030B
ZA988030B ZA988030A ZA988030A ZA988030B ZA 988030 B ZA988030 B ZA 988030B ZA 988030 A ZA988030 A ZA 988030A ZA 988030 A ZA988030 A ZA 988030A ZA 988030 B ZA988030 B ZA 988030B
Authority
ZA
South Africa
Prior art keywords
fracture healing
pthrp analogs
pthrp
analogs
healing
Prior art date
Application number
ZA988030A
Other languages
English (en)
Inventor
Brian Henry Vickery
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA988030B publication Critical patent/ZA988030B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA988030A 1997-09-09 1998-09-02 Fracture healing using pthrp analogs ZA988030B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5832497P 1997-09-09 1997-09-09

Publications (1)

Publication Number Publication Date
ZA988030B true ZA988030B (en) 1999-03-09

Family

ID=22016113

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA988030A ZA988030B (en) 1997-09-09 1998-09-02 Fracture healing using pthrp analogs

Country Status (32)

Country Link
US (1) US6583114B2 (pt)
EP (1) EP1005359B1 (pt)
JP (1) JP2002509854A (pt)
KR (1) KR100679778B1 (pt)
CN (1) CN1210059C (pt)
AR (1) AR015435A1 (pt)
AT (1) ATE297754T1 (pt)
AU (1) AU752925B2 (pt)
BR (1) BR9812068A (pt)
CA (1) CA2302255C (pt)
CO (1) CO4890856A1 (pt)
CZ (1) CZ298701B6 (pt)
DE (1) DE69830591T2 (pt)
ES (1) ES2244090T3 (pt)
HK (1) HK1030753A1 (pt)
HR (1) HRP20000109A2 (pt)
HU (1) HU226866B1 (pt)
IL (2) IL134719A0 (pt)
MA (1) MA26545A1 (pt)
MY (1) MY121291A (pt)
NO (1) NO323740B1 (pt)
NZ (1) NZ502970A (pt)
PE (1) PE117399A1 (pt)
PL (1) PL195703B1 (pt)
RS (1) RS49707B (pt)
RU (1) RU2224539C2 (pt)
SA (1) SA98190565B1 (pt)
TR (1) TR200000649T2 (pt)
TW (1) TW552139B (pt)
UY (1) UY25172A1 (pt)
WO (1) WO1999012561A2 (pt)
ZA (1) ZA988030B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1769804B1 (en) * 1998-08-19 2012-09-19 Eli Lilly And Company hPTH(1-34) for use in preventing or reducing the incidence or severity of vertebral and / or non vertebral fracture in a male human
DZ2873A1 (fr) 1998-08-19 2003-12-15 Lilly Co Eli Procédé pour augmenter la dureté et la rigidité osseuse.
US20040033950A1 (en) 2000-09-26 2004-02-19 Hock Janet M. Method of increasing bone toughness and stiffness and reducing fractures
EP1136076A1 (en) * 1998-08-19 2001-09-26 Eli Lilly And Company Method of increasing bone toughness and stiffness and reducing fractures
CA2245903A1 (en) * 1998-09-28 2000-03-28 Mcgill University Use of pex in the treatment of metabolic bone diseases
AU766163B2 (en) 1999-03-05 2003-10-09 Duke University C16 unsaturated fp-selective prostaglandins analogs
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US6675048B2 (en) * 2000-05-08 2004-01-06 International Rehabilitative Sciences, Inc. Electro-medical device for use with biologics
US6393328B1 (en) * 2000-05-08 2002-05-21 International Rehabilitative Sciences, Inc. Multi-functional portable electro-medical device
US6560487B1 (en) * 2000-05-08 2003-05-06 International Rehabilitative Sciences, Inc. Electro-medical device for use with biologics
WO2003059291A2 (en) * 2002-01-10 2003-07-24 Osteotrophin Llc Treatment of bone disorders with skeletal anabolic drugs
AU2003272814A1 (en) 2003-10-02 2005-05-19 Ibrahim Al-Habdan Peptide for promoting healing of fractures
CA2584095A1 (en) * 2004-10-08 2006-04-20 Forbes Medi-Tech (Research) Inc. Vasoactive intestinal polypeptide pharmaceuticals
US7994129B2 (en) * 2005-11-10 2011-08-09 Michigan Technological University Methods of using black bear parathyroid hormone
WO2007133580A2 (en) * 2006-05-09 2007-11-22 Zelos Therapeutics, Inc. Use of pth (1-31) and optionally g-csf for hematopoietic stimulation
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
PT2957278T (pt) 2006-10-03 2017-08-23 Ipsen Pharma Sas Uma composição estável compreendendo pthrp e utilizações da mesma
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
EP1961765A1 (en) * 2006-12-08 2008-08-27 Zealand Pharma A/S Truncated PTH peptides with a cyclic conformation
JP5564167B2 (ja) * 2008-05-22 2014-07-30 日本たばこ産業株式会社 苦味マスキング剤及び苦味低減方法
US8870876B2 (en) 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
EP2411038B1 (en) 2009-03-27 2016-12-28 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
WO2011071480A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
CN104146961B (zh) * 2014-07-04 2018-02-27 深圳职业技术学院 一种薄膜蒸发法制备载细胞因子和骨蛋白微球的方法
EP4039253A1 (en) 2015-04-29 2022-08-10 Radius Pharmaceuticals, Inc. Methods of treating cancer
CN108025042A (zh) * 2015-07-06 2018-05-11 董正欣 PTHrP类似物的新型制剂
CA3020333A1 (en) 2016-04-18 2017-10-26 Radius Health, Inc. Formulations of abaloparatide, transdermal patches thereof, and uses thereof
EP3565542B1 (en) 2017-01-05 2024-04-10 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
AU2019297421A1 (en) 2018-07-04 2021-01-28 Radius Pharmaceuticals, Inc. Polymorphic forms of RAD 1901-2HCL
WO2021051082A1 (en) * 2019-09-12 2021-03-18 Radius Health, Inc. Methods of improving spinal fusion with abaloparatide
CN112646042A (zh) * 2019-10-10 2021-04-13 陕西麦科奥特科技有限公司 活性多肽化合物
JP2024502334A (ja) * 2021-01-05 2024-01-18 ラジウス ヘルス，インコーポレイテッド アバロパラチドを用いた長骨骨折の治療

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3935738A1 (de) * 1989-10-27 1991-05-08 Forssmann Wolf Georg Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
US5977070A (en) * 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
US5821225A (en) * 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
WO1995002610A1 (en) * 1993-07-13 1995-01-26 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
TW273513B (pt) * 1993-10-27 1996-04-01 Chugai Pharmaceutical Co Ltd
JPH08310965A (ja) * 1995-05-16 1996-11-26 Chugai Pharmaceut Co Ltd 骨癒合促進剤
US5717062A (en) * 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone

Also Published As

Publication number Publication date
TW552139B (en) 2003-09-11
DE69830591D1 (de) 2005-07-21
EP1005359A2 (en) 2000-06-07
RS49707B (sr) 2007-12-31
DE69830591T2 (de) 2006-05-04
EP1005359B1 (en) 2005-06-15
HUP0004560A3 (en) 2005-11-28
YU12700A (sh) 2004-09-03
NZ502970A (en) 2002-03-01
CA2302255A1 (en) 1999-03-18
CO4890856A1 (es) 2000-02-28
UY25172A1 (es) 2001-01-31
PL195703B1 (pl) 2007-10-31
CZ2000862A3 (cs) 2000-09-13
NO323740B1 (no) 2007-07-02
AR015435A1 (es) 2001-05-02
CN1210059C (zh) 2005-07-13
US6583114B2 (en) 2003-06-24
CZ298701B6 (cs) 2007-12-27
ES2244090T3 (es) 2005-12-01
KR100679778B1 (ko) 2007-02-07
HU226866B1 (en) 2009-12-28
ATE297754T1 (de) 2005-07-15
KR20010023795A (ko) 2001-03-26
WO1999012561A9 (en) 2000-03-16
AU9740698A (en) 1999-03-29
HRP20000109A2 (en) 2001-02-28
IL134719A0 (en) 2001-04-30
TR200000649T2 (tr) 2000-09-21
HUP0004560A2 (hu) 2001-04-28
NO20001195L (no) 2000-03-08
PL339449A1 (en) 2000-12-18
CA2302255C (en) 2011-11-08
WO1999012561A2 (en) 1999-03-18
PE117399A1 (es) 1999-11-20
CN1269726A (zh) 2000-10-11
MY121291A (en) 2006-01-28
WO1999012561A3 (en) 1999-05-14
BR9812068A (pt) 2000-09-26
MA26545A1 (fr) 2004-12-20
SA98190565B1 (ar) 2006-07-30
AU752925B2 (en) 2002-10-03
US20020077281A1 (en) 2002-06-20
RU2224539C2 (ru) 2004-02-27
IL134719A (en) 2010-04-29
JP2002509854A (ja) 2002-04-02
HK1030753A1 (en) 2001-05-18
NO20001195D0 (no) 2000-03-08

Similar Documents

Publication Publication Date Title
HUP0004560A3 (en) Fracture healing using pthrp analogs
ZA983176B (en) Therapeutic compounds
SI0948541T1 (sl) PTHrP analogi
EP0996458A4 (en) SANDRAMYCIN ANALOG
GB9808665D0 (en) Therapeutic compounds
PL338781A1 (en) Dosage form
GB9716345D0 (en) Therapeutic compounds
EP0981545A4 (en) TREATMENT OF OSTEOPOROSIS
GB9700875D0 (en) Medical devices
GB9716347D0 (en) Therapeutic compounds
GB9716344D0 (en) Therapeutic compounds
GB9824897D0 (en) Therapeutic compounds
GB2323042B (en) Nebulisers
IL120955A0 (en) Treatment of osteoporosis
GB9827865D0 (en) Medicament
GB9808667D0 (en) Therapeutic compounds
GB9718683D0 (en) Novel dosage form
GB2329335B (en) Medicament
GB9719261D0 (en) Dosage forms
GB9704978D0 (en) Dosage forms
GB0002424D0 (en) Medicament
GB9702946D0 (en) Medicament
GB9726234D0 (en) Medicament
HUP9903097A3 (en) Medicament containing progestogen-anti-progestogen
GB9714742D0 (en) Medical cement